LS-P-START

LS-P-START: A phase I study with a novel IL-2 (DF6215) for solid tumors

Status:

Open

Trial Type:

Early Phase Trials for Multiple Cancer Types, Kidney and Bladder Cancer

Contact:

Benedito Carneiro, MD

Benedito.carneiro@brownhealth.org